A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity Carlos RosalesViviana Valadez GrahamRicardo Rosales ORIGINAL ARTICLE Pages: 347 - 360
Local injections of OK432 can help the infiltration of adoptively transferred CD8+ T cells into the tumor sites and synergistically induce the local production of Th1-type cytokines and CXC3 chemokines Katsunori TatsugamiKoji TamadaKikuo Nomoto ORIGINAL ARTICLE Pages: 361 - 368
Killing of Fas ligand-resistant renal carcinoma cells by interleukin-2- and BCG-activated effector cells Sven BrandauHenrik SuttmannAndreas Böhle ORIGINAL ARTICLE Pages: 369 - 376
Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels Øystein BruserudElling Ulvestad ORIGINAL ARTICLE Pages: 377 - 387
Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer Patrizia PellegriniIda ContastaDomenico Adorno ORIGINAL ARTICLE Pages: 388 - 394
Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial Manuela SchmidingerGünther G. Stegerfor the Austrian Renal Cell Carcinoma Study Group ORIGINAL ARTICLE Pages: 395 - 400